Tai-Chi, Topical Capsaicin Among the New Treatment Recommendations for Osteoarthritis
The American College of Rheumatology (ACR), in partnership with the Arthritis Foundation, has issued treatment guidelines for osteoarthritis of the hand, hip and knee. This is the first update since 2012.
Learn more
 
Secukinumab Benefits in Psoriatic Arthritis Persist for 5 Years
Secukinumab (Cosentyx, Novartis) provided sustained improvements through five years in the signs and symptoms of psoriatic arthritis with no new safety signals, say researchers recently writing in ACR Open Rheumatology.
Learn more
 
11 Considerations for Tapering Biologic Therapy in Inflammatory Arthritis
In a review published last month in Autoimmunity Reviews, British researchers outline factors physicians should consider when contemplating tapering biologic therapies in patients with inflammatory arthritis. How best to wean patients from biologic therapy is an issue that comes up more frequently these days as patients increasingly achieve remission or low disease activity. In this slideshow, we highlight considerations physicians may want to consider in treating these patients.
Learn more
 
• PsA Quiz: Monotherapy and Joint Destruction
• PsA Quiz: Five forms of PsA
• PSA Quiz: New Treatments
 
Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.